KT&G's Approach to Vapor Products in Korea

Dec.30.2022
KT&G's Approach to Vapor Products in Korea
KT&G focuses on HNB products, combining vaporization and heating technology, and has not developed a separate vape brand due to government regulations.

Why has KT&G not launched a separate vape brand, despite having its current range of heated tobacco products such as Lil, Fiit, and MIX series?

 

As early as 2019, the South Korean Ministry of Health and Welfare recommended that the public stop using vapes and promised to quickly determine whether to ban the sale of e-cigarettes.

 

In October 2022, the Ministry of Health and Welfare in South Korea issued a strong recommendation regarding vape use, advising people to stop using the product until results from relevant harmfulness tests are released. Additionally, the South Korean government proposed a series of improvement measures to eliminate the regulatory "dead zone" for e-cigarettes.

 

The Korean Electronic Cigarette Association has stated that the government's recommendation only covers atomized products in electronic cigarettes. Following the government's strong suggestion, sales of Korean vapes plummeted by 70%.

 

The South Korean government's plan to ban e-cigarettes may have an impact on local company KT&G's e-cigarette sales. KT&G issued a statement claiming that their products do not contain harmful substances and that they will cooperate with the government's investigation.

 

Due to policy factors, KT&G has not devoted much research and development to vaporized electronic cigarettes. However, KT&G does possess vaporization technology, but according to its current product strategy focus on heat-not-burn products, it has combined the vaporization technology with non-combustion heating technology, applying both to its HNB brand products.

 

Using KT&G's Lil series products as an example, there are three main characteristics of the products: firstly, the combination of atomization and non-combustion heating technologies heats the pod up to 160 degrees, improving the taste and increasing smoke volume; secondly, the heating chamber of the pod is circular and does not come into contact with the tobacco, making it easy to clean; thirdly, the dual-core heating technology expands the heating area of the tobacco, resulting in more uniform heating.

 

The Lil series product booth of KT&G. Image source: Tobacco Online.

 

On December 12th, KT&G announced that they will expand the sales points of their new product from the Lil series, "lil AIBLE", to 20,000 locations. This includes an addition of 11,095 convenience stores in major cities such as Seoul, Busan, Incheon, Daegu, Gwangju, Sejong, Suwon, and Seongnam.

 

This shows that KT&G places a high importance on HNB products.

 

Table 1: Some Product Brands of KT&G and the Four Major Tobacco Companies.

 

Image source: Created by 2FIRSTS.

 

Products and technology of the big four tobacco companies.

 

The IQOS series of Heat-Not-Burn (HNB) products from Philip Morris International are primarily characterized by their central heating process, which heats tobacco to 350 degrees without combustion. This results in the release of a vapor containing salts and alkanes which reduces harmful substances. The IQOS Mesh line of vaporization products is characterized by the production of smoke from heating water vapor without tar, using a pod with a mesh design.

 

The unique features of the GIO series HNB products by British American Tobacco are as follows: First, heating is done in stages controlled by intelligent electronic devices to ensure the best flavor. Second, the heating method is a four-way radiating pattern from the center. Third, the pods are thinner and longer, resulting in faster heating. Fourth, the inhalable aerosol contains nicotine and has about 90-95% lower toxicity compared to conventional cigarettes. Finally, a special method of decomposing the tobacco into particle form within the pod resolves the issue of nicotine concentration limits by heating the tobacco at 240℃.

 

The Vuse series of atomization products from British American Tobacco uses the FEELM ceramic core developed by Smoore International, combining a metal film with a ceramic conductor to significantly improve flavor, consistency, and transmission efficiency. Vuse e-cigarettes received their PMTA last year, becoming the first FDA-authorized brand.

 

Japanese Tobacco has launched two types of pods for its Ploom S series of HNB products: regular and menthol. The selection of flavors is limited. The product uses ring heating technology, which is known for its low efficiency in heat utilization. The low temperature heating of the device results in a less intense flavor for the regular type, while the menthol type provides a cool sensation with its refreshing formula.

 

Eight products from the Logic line of vapor products under Japan Tobacco have received authorization from the United States Food and Drug Administration's Pre-Market Tobacco Application (PMTA) process. The Logicvape products include cotton products such as Logicpower and pro, as well as Logic Vapeleaf, which is a heat-not-burn (HNB) product similar to Ploom tech. The main difference is that it heats tobacco capsules with vapor at a lower temperature.

 

Imperial Tobacco's Pulze series HNB (heat-not-burn) products utilize an "inside-out" heating technology with two modes: 345-degree high temperature and 315-degree low temperature. The Blu series atomized products use nicotine salt technology, which increases nicotine concentration in the bloodstream compared to regular e-cigarettes and also allows for faster absorption.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin's electronic vaping device directory has been fully enforced for more than a year, and local vape retailers say the reduced range of eligible products has contributed to declining sales, store closures and layoffs. Johnny Vapes owner Ben Hall said he has closed four of seven locations and cut about 70% of his staff. State law bars the sale of vaping devices not listed on the Wisconsin Department of Revenue directory and allows penalties of $1,000 per day for each unlisted device sold or offered for sale. In April 2026, the U.S. Court of Appeals for the Seventh Circuit allowed enforcement of the law to continue.
Regulations
Oct.10
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
From a 2017 Launch to 48% of South Korea’s Heated Tobacco Market, KT&G Looks Back on a Decade of lil
From a 2017 Launch to 48% of South Korea’s Heated Tobacco Market, KT&G Looks Back on a Decade of lil
KT&G announced on Aug. 13, 2026, that it has opened “lil Archive,” a brand exhibition space in Seoul showcasing the evolution, technology platforms and future direction of its heated tobacco brand lil since its launch in 2017. KT&G said lil now spans three major platforms — lil SOLID, lil HYBRID and lil AIBLE — with more than 30 dedicated consumables, and held a 48% share of South Korea's heated tobacco market in the second quarter of 2026. The opening comes as lil enters its 10th year, with KT&G continuing to position the brand for expansion beyond its domestic market.
Aug.14
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19